CrossrefInfokarte
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
Lung Cancer: Targets and Therapy · 2026-02 · Volume 17 · 1-10
DOI: 10.2147/lctt.s555262 ↗Abstract
Kein Abstract verfügbar.
EUVIMED